PTO Form 1478 (Rev 9/2006) |
OMB No. 0651-0009 (Exp 09/30/2008) |
Trademark/Service Mark Application, Principal Register
Serial Number: 77072416 |
Filing Date: 12/28/2006 |
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
77072416 |
MARK INFORMATION |
*MARK |
RALTICO |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
RALTICO |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font, style, size, or color. |
APPLICANT INFORMATION |
*OWNER OF MARK |
Warner-Lambert Company LLC |
*STREET |
235 East 42nd Street |
*CITY |
New York |
*STATE
(Required for U.S. applicants) |
New York |
*COUNTRY |
United States |
*ZIP/POSTAL CODE
(Required for U.S. applicants only) |
10017 |
PHONE |
212-733-5578 |
FAX |
212-573-2273 |
LEGAL ENTITY INFORMATION |
*TYPE |
LIMITED LIABILITY COMPANY |
*STATE/COUNTRY WHERE LEGALLY ORGANIZED |
Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION |
INTERNATIONAL CLASS |
005 |
DESCRIPTION |
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious,
inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders;
pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations,
dermatological preparations, smoking cessation preparations. |
FILING BASIS |
SECTION 1(b) |
ATTORNEY INFORMATION |
NAME |
Eric McCormick |
ATTORNEY DOCKET NUMBER |
US/RALTICO/02.02.01 |
FIRM NAME |
Pfizer Inc. |
STREET |
150 East 42nd Street |
INTERNAL ADDRESS |
Trademark Department- 5th Floor MS26 |
CITY |
New York |
STATE |
New York |
COUNTRY |
United States |
ZIP/POSTAL CODE |
10017 |
PHONE |
212-733-5578 |
FAX |
212-573-2273 |
OTHER APPOINTED ATTORNEY |
Eric McCormick and Arthur Silverstein, Tiffany Trunko, Jennet Walker, Stacey Hallerman, Cindy Zelson, Heather McDonald, Jane Ungaro, Christopher Bolinger, Jake Feldman, Matthew
Pater, Seana Smith and Richard Friedman |
CORRESPONDENCE INFORMATION |
NAME |
Eric McCormick |
FIRM NAME |
Pfizer Inc. |
STREET |
150 East 42nd Street |
INTERNAL ADDRESS |
Trademark Department- 5th Floor MS26 |
CITY |
New York |
STATE |
New York |
COUNTRY |
United States |
ZIP/POSTAL CODE |
10017 |
PHONE |
212-733-5578 |
FAX |
212-573-2273 |
FEE INFORMATION |
NUMBER OF CLASSES |
1 |
FEE PER CLASS |
325 |
TOTAL FEE DUE |
325 |
SIGNATURE INFORMATION |
SIGNATURE |
/Eric McCormick/ |
SIGNATORY'S NAME |
Eric McCormick |
SIGNATORY'S POSITION |
Corporate Counsel- Trademarks |
DATE SIGNED |
12/28/2006 |
FILING INFORMATION SECTION |
SUBMIT DATE |
Thu Dec 28 11:17:10 EST 2006 |
TEAS STAMP |
USPTO/BAS-XXX.XX.XXX.XX-2
0061228111710923674-77072
416-36047c6afe79ec0a0dd5d
28adc58fee5d9-DA-1158-200
61228104545804822 |
PTO Form 1478 (Rev 9/2006) |
OMB No. 0651-0009 (Exp 09/30/2008) |
Trademark/Service Mark Application, Principal Register
Serial Number: 77072416 |
Filing Date: 12/28/2006 |
To the Commissioner for Trademarks:
MARK: RALTICO (Standard Characters, see
mark)
The literal element of the mark consists of RALTICO. The mark consists of standard characters, without claim to any particular font, style, size, or color.
The applicant, Warner-Lambert Company LLC, a limited liability company legally organized under the laws of Delaware, having an address of 235 East 42nd Street, New York, New York, United States,
10017, requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15
U.S.C. Section 1051 et seq.), as amended.
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal,
gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital,
urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical
preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations.
If the applicant is filing under Section 1(b), intent to use, the applicant declares that it has a bona fide intention to use or use through the applicant's related company or licensee the mark in
commerce on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(b), as amended.
If the applicant is filing under Section 1(a), actual use in commerce, the applicant declares that it is using the mark in commerce, or the applicant's related company or licensee is using the mark
in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended.
If the applicant is filing under Section 44(d), priority based on foreign application, the applicant declares that it has a bona fide intention to use the mark in commerce on or in connection with
the identified goods and/or services, and asserts a claim of priority based on a specified foreign application(s). 15 U.S.C. Section 1126(d), as amended.
If the applicant is filing under Section 44(e), foreign registration, the applicant declares that it has a bona fide intention to use the mark in commerce on or in connection with the identified
goods and/or services, and submits a copy of the supporting foreign registration(s), and translation thereof, if appropriate. 15 U. S.C. Section 1126(e), as amended.
The applicant hereby appoints Eric McCormick and Eric McCormick and Arthur Silverstein, Tiffany Trunko, Jennet Walker, Stacey Hallerman, Cindy Zelson, Heather McDonald, Jane Ungaro, Christopher
Bolinger, Jake Feldman, Matthew Pater, Seana Smith and Richard Friedman of Pfizer Inc., Trademark Department- 5th Floor MS26, 150 East 42nd Street, New York, New York, United States, 10017 to submit
this application on behalf of the applicant. The attorney docket/reference number is US/RALTICO/02.02.01.
Correspondence Information: |
Eric McCormick |
|
Trademark Department- 5th Floor MS26 |
|
150 East 42nd Street |
|
New York, New York 10017 |
|
212-733-5578(phone) |
|
212-573-2273(fax) |
A fee payment in the amount of $325 will be submitted with the application, representing payment for 1 class(es).
Declaration
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the
applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes
applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either
in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake,
or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.
Signature: /Eric McCormick/ Date Signed: 12/28/2006
Signatory's Name: Eric McCormick
Signatory's Position: Corporate Counsel- Trademarks
RAM Sale Number: 1158
RAM Accounting Date: 12/28/2006
Serial Number: 77072416
Internet Transmission Date: Thu Dec 28 11:17:10 EST 2006
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XX-2006122811171092
3674-77072416-36047c6afe79ec0a0dd5d28adc
58fee5d9-DA-1158-20061228104545804822